Technology, Scale, and Capital: Advancing UK Drug Discovery and Development 

A three-part global event series focused on technology, innovation, and investment in early-stage drug discovery. Bringing together senior executives, R&D leaders and lab managers from pharma and biotech companies, the series provides a unique platform for industry suppliers to connect with key buyers and influencers. Attendees also include leaders from academia, start-ups, spin-outs, and the investment community, creating a highly collaborative environment for partnership, innovation, and business growth.

*One Nucleus members receive 10% discount off registration, please contact [email protected] for details